These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 13702241)

  • 1. [On the pharmacodynamics of 3-pyrrolidinylbutyranilide or WS-10, a basal neuroleptic, a cortical thymoleptic].
    FROMMEL E; FLEURY C; WILDER SMITH AE; VINCENT D
    Arch Int Pharmacodyn Ther; 1961 Mar; 130():235-59. PubMed ID: 13702241
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electroencephalographic viewpoints on the classification of neuroleptic and thymoleptic drugs. I. Methodical problems in the electroencephalographic classification of neuroleptic and thymoleptic drugs].
    BENTE D
    Med Interna (Bucur); 1961; 5():337-46. PubMed ID: 13867369
    [No Abstract]   [Full Text] [Related]  

  • 3. Uptake of 3H-noradrenaline (3H-NA) in plasma from patients treated with thymoleptic or neuroleptic drugs.
    Tuck D; Hamberger B; Sjöqvist F
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):87. PubMed ID: 5314453
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigations into the mechanism of action of neuroleptic drugs.
    GOZSY B; KATO L
    Arch Int Pharmacodyn Ther; 1960 Oct; 128():75-81. PubMed ID: 13707589
    [No Abstract]   [Full Text] [Related]  

  • 5. General ideas on the pharmacodynamics of tranquilizing agents.
    DELGA J
    Rev Int Serv Sante Armees; 1961; 34():67-74. PubMed ID: 13721557
    [No Abstract]   [Full Text] [Related]  

  • 6. [General ideas concerning the pharmacodynamics of tranquilizing agents].
    DELGA J
    Strasb Med; 1960 Nov; 11():729-40. PubMed ID: 13721556
    [No Abstract]   [Full Text] [Related]  

  • 7. [The pharmacodynamics of the glycols used as tranquilizing agents].
    DELGA J; MIZOULE J
    Rev Int Serv Sante Armees; 1961 Mar; 34():75-9. PubMed ID: 13721555
    [No Abstract]   [Full Text] [Related]  

  • 8. [The pharmacodynamics of the diols used as tranquilizing agents].
    DELGA J; MIZOULE J
    Strasb Med; 1960 Nov; 11():741-6. PubMed ID: 13721554
    [No Abstract]   [Full Text] [Related]  

  • 9. [Psycho-organic stages in the use of so-called neuroleptic drugs].
    BARUK H; LAUNAY J
    Rev Neurol (Paris); 1959 Jun; 100():767-71. PubMed ID: 13797345
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanims of thymoleptic drug action studied on the model of apomorphine depression].
    Tesarová O
    Act Nerv Super (Praha); 1968 Oct; 10(3):287-8. PubMed ID: 5702530
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of psychotropic agents from the psychoplegic and thymoleptic groups on central thermoregulation mechanisms].
    Rewerski W
    Pol Tyg Lek; 1974 Jun; 29(25):1093-5. PubMed ID: 4407760
    [No Abstract]   [Full Text] [Related]  

  • 12. The purely neuroleptic effects and its relation to the "neuroleptic threshold".
    Haase HJ
    Acta Psychiatr Belg; 1978; 78(1):19-36. PubMed ID: 645405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The possibilities of quantitative utilization of electroencephalographic serial studies in neuroleptic therapy].
    HELMCHEN H; KUENKEL H
    Med Esp; 1960; 2():95-102. PubMed ID: 14400926
    [No Abstract]   [Full Text] [Related]  

  • 14. The frog as a subject for screening thymoleptic drugs.
    Lapin IP; Oxenkrug GF; Osipova SV; Uskova NV
    J Pharm Pharmacol; 1970 Oct; 22(10):781-2. PubMed ID: 4394786
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of neuroleptic substances on the cortical reticular system of the brain (a histochemical and biochemical study)].
    Absava GI; Markin VA
    Farmakol Toksikol; 1973; 36(5):653-7. PubMed ID: 4802198
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical implications of dopaminergic and cholinergic effects of neuroleptic drugs.
    Stimmel GL
    Hosp Pharm; 1976 Feb; 11(2):50-1, 54-6. PubMed ID: 10235740
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of dopamine-sensitive adenylate cyclase in rat basal ganglia and other hormone sensitive adenylate cyclase systems by neuroleptic drugs.
    Miller R
    Br J Pharmacol; 1975 Mar; 53(3):457P-458P. PubMed ID: 1137755
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the pharmacodynamics of a new tranquilizing agent with relaxing and anti-tremor effect and a prolonged duration of action: Go 560 or 3-(3-butoxy-2-carbamoyl-2-hydroxypropyl)-5-phenyl-5-ethylbarbituric acid. Experimental study].
    FROMMEL E; GOLD-AUBERT P; FLEURY C; SCHMIDT-GINZKEY J; BEGUIN M
    Helv Physiol Pharmacol Acta; 1961; 19():241-53. PubMed ID: 13702243
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the pharmacology of the thymoleptic noxiptilin (Bay 1521)].
    Hoffmeister F; Wuttke W; Kroneberg G
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:846+. PubMed ID: 5819764
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of various neuroleptic and tranquilizing agents on the sensitivity of the central nervous system to acetylcholine, adrenalin and serotonin].
    Chauchard P; Mazoué H
    C R Seances Soc Biol Fil; 1966; 160(3):494-5. PubMed ID: 4224394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.